Newsfeeds - Spark Newswire

4 minute read

Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

Today, 3:53 AM

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.

ALLR

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 3:53 AM

Gainers Jaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday’s regular session. The current volume of 532.2K…

AKAN

1 minute read

Needham Maintains Buy on Pliant Therapeutics, Raises Price Target to $45

By Benzinga Newsdesk

Today, 3:53 AM

Needham analyst Joseph Stringer maintains Pliant Therapeutics (NASDAQ:PLRX) with a Buy and raises the price target from $40 to $45.

PLRX

2 minute read

Dow Jumps Over 300 Points; Crude Oil Up 1%

By Lisa Levin

Today, 3:53 AM

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 30 points on Monday. The Dow traded up 0.94% to 33,687.69 while the NASDAQ rose 1.93% to 11,355.16. The S&P 500 also rose, gaining, 1.31% to 4,024.60.

ANPC

1 minute read

Cantor Fitzgerald Maintains Overweight on Pliant Therapeutics, Raises Price Target to $52

By Benzinga Newsdesk

Today, 3:53 AM

Cantor Fitzgerald analyst Pete Stavropoulos maintains Pliant Therapeutics (NASDAQ:PLRX) with a Overweight and raises the price target from $40 to $52.

PLRX

2 minute read

US Stocks Mostly Higher; Synchrony Financial Earnings Top Views

By Lisa Levin

Today, 3:53 AM

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 90 points on Monday.

COSM

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 3:53 AM

Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 7026.4% to $6.04 during Monday’s pre-market session. The market value…

ADIL

1 minute read

Pliant Therapeutics Stock Surges After Positive Data From Lead Program In Scarred Lung Disorder

By Vandana Singh

Today, 3:53 AM

Pliant Therapeutics Inc (NASDAQ: PLRX) has announced 12-week interim data from the 320 mg dose group of INTEGRIS-IPF Phase 2a clinical trial of bexotegrast (PLN-74809) in patients with idiopathic pulmonary fibrosis (IPF).

PLRX

1 minute read

Pliant Therapeutics Earlier Announced Data From The Integris-IPF Phase 2a Trial Demonstrating Bexotegrast 320 Mg Was Well Tolerated And Achieved Statistically Significant FVC Increase In Patients With Idiopathic Pulmonary Fibrosis; Trial Met Primary An…

By Charles Gross

Today, 3:53 AM

Pliant Therapeutics, Inc. (NASDAQ: PLRX) today announced 12-week interim data from the 320 mg dose group of INTEGRIS-IPF, a multinational, randomized, double-blind, placebo-controlled Phase 2a clinical trial of bexotegrast (PLN-74809) in patients with idiopathic pulmonary fibrosis (IPF).

PLRX

1 minute read

JP Morgan Initiates Coverage On Pliant Therapeutics with Overweight Rating, Announces Price Target of $42

By Benzinga Newsdesk

Today, 3:53 AM

JP Morgan analyst Eric Joseph initiates coverage on Pliant Therapeutics (NASDAQ:PLRX) with a Overweight rating and announces Price Target of $42.

PLRX